Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 196.10
-0.75 (-0.38%)
At close: Jul 31, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 259.61 billion as of July 31, 2026. Its market cap has decreased by -2.91% in one year.
Market Cap
259.61B
Enterprise Value
303.17B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
196.10
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 259.61B, an increase of 14.50%. That is a compound annual growth rate of 3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 259.61B | 13.53% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 589.03B |
| GlaxoSmithKline Pharmaceuticals | 445.09B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 247.16B |
| Granules India | 206.66B |
| AstraZeneca Pharma India | 204.48B |
| Caplin Point Laboratories | 192.62B |
| Jubilant Pharmova | 152.25B |